Fennec Pharmaceuticals Inc (FRX) Stock Price & News

FRX:TSE

Fennec Pharmaceuticals Inc

CA$14.51

-2.09%

(-0.31) 1D

Oct 2, 4:00:00 PM GMT-4 · CAD

All symbols

	Symbol	Price	Change	% Change

Last report

Aug 11, 2026

Fiscal period

Q2 2026

EPS / Est. (USD)

- / $0.02

Revenue / Est. (USD)

17.87M / 16.12M

Fiscal Q2 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in USD

Loading Previous Earnings...

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	12.46M	13.78M	15.11M	17.87M
Cost of goods sold	660.00K	1.76M	570.00K	721.00K
Cost of revenue	660.00K	1.76M	570.00K	721.00K
Research and development expenses	29.00K	20.00K	49.00K	118.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	11.96M	14.55M	14.61M	15.30M
Operating expense	11.99M	14.57M	14.66M	15.42M
Total operating expenses	12.65M	16.33M	15.23M	16.14M
Operating income	-189.00K	-2.55M	-119.00K	1.74M
Other non operating income	-	-	-	-
EBT including unusual items	-638.00K	-4.68M	201.00K	2.02M
EBT excluding unusual items	-638.00K	-2.66M	201.00K	2.02M
Income tax expense	-	106.00K	-	42.00K
Effective tax rate	-	-2.26%	-	2.08%
Other operating expenses	-	-	-	-
Net income	-638.00K	-4.79M	201.00K	1.97M
Net profit margin	-5.12%	-34.75%	1.33%	11.04%
Earnings per share	-0.02	-0.10	-	-
Interest and investment income	152.00K	228.00K	339.00K	287.00K
Interest expense	-598.00K	-334.00K	-7.00K	-3.00K
Net interest expenses	-446.00K	-106.00K	332.00K	284.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-163.00K	-2.53M	-93.00K	1.76M
Gain or loss from assets sale	-	-	-	-

Finance